-
Carmaker Stellantis swings back into profit as sales climb
-
Trump warns Iran blockade could last months, sending oil prices soaring
-
Pistons stay alive, Lakers can't stop Rockets
-
No 'meaningful' shift from social media sites after Australia teen ban: govt report
-
Denmark's Soren Torpegaard Lund to 'stay true' at Eurovision
-
Marathon brothers run Ireland in race to find dementia cure
-
Inoue wary of 'clever' Nakatani in sold-out Tokyo superfight
-
Australian Jewish group warned of 'attack' before Bondi mass shooting: inquiry
-
Mamdani calls on King Charles to return Koh-i-Noor diamond
-
New Zealand mosque killer loses bid to overturn convictions
-
Oil at four-year high, stocks slip after Trump blockade warning
-
Key points from the first global talks on phasing out fossil fuels
-
Mountain festival marks spring arrival high above Tokyo
-
Nations urged to 'go further' as fossil fuel exit talks wrap in Colombia
-
Australia's 'most beautiful' street fed up with viral fame
-
Top-seeded Pistons stay alive in playoffs with Magic win
-
Cuban boy's sporting dreams on hold as surgery backlog grows
-
Bali drowning in trash after landfill closed
-
Australian Jewish group warned of 'terrorist attack' before Bondi shooting: inquiry
-
Finland's Eurovision favourite brings flames and a frantic violin to Vienna
-
ECB set to hold rates despite Iran war energy shock
-
Iran, World Cup loom over FIFA Congress
-
Samsung Electronics posts record quarterly profit on AI boom
-
D4vd used Amazon chainsaws to hack up teen's body: prosecutors
-
Caledonia Mining Corporation Plc: Change of Chairman
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 30
-
Route1 Reports Fiscal Year 2025 Results and Continued Transition Toward Recurring, Lifecycle-Based Revenue
-
InHand Networks FWA12 5G FWA Router: Ideal Connectivity for Multi-Store Retail & Hospitality
-
Meta chief Zuckerberg doubles down on AI spending
-
Saudi to end LIV Golf funding this year: reports
-
Google-parent Alphabet soars as Meta stumbles over AI costs
-
Powell's decision to stay on at Fed ignites new Trump insult
-
Brazil lowers benchmark rate to 14.5% in second consecutive cut
-
'This cannot happen': Arsenal's Arteta livid over Eze penalty review
-
Air quality improving in Europe but more effort needed: report
-
Putin, Trump discuss Iran, Ukraine in phone call: Kremlin
-
Crazy flights: Kiss frontman produces plane disaster movie
-
Google-parent Alphabet soars as rivals stumble over AI costs
-
Romanian behind 'swatting' attacks in US gets four years in prison
-
Arsenal, Atletico trade penalties in Champions League semi-final draw
-
Anti-Bezos campaign urges Met Gala boycott in New York
-
African oil producers defend need to drill at fossil fuel exit talks
-
Iran officials leave Canada before FIFA Congress over airport 'insult': Iranian media
-
Oil spikes while divided Federal Reserve keeps interest rates unchanged
-
Palace boss Glasner eager for another trophy in Europe
-
Alleged Trump assassin took selfie moments before attack: prosecutors
-
Shomrim: the Jewish volunteers protecting their community
-
Powell to bow out as Fed chief but stay as a governor on legal pressure
-
PSG blow as Hakimi ruled out of Champions League semi-final return
-
'Gritty' Philadelphia pitches itself as low-cost US World Cup choice
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond.
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Ignite, a performance formula designed for men aged 35+ seeking natural support for vitality, recovery, and focus. Ignite combines clinically respected botanicals with full spectrum CBD to help men perform at their best in every aspect of life.

"More men are looking for natural solutions to support vitality and confidence," said Joseph Dowling, CEO of CV Sciences. "With Ignite, we've combined our expertise in hemp-based nutrition with nature's most respected male vitality botanicals to deliver a comprehensive formula for modern men. This exciting new product is now available on our website and soon to be available in select health food stores across the country."
Ignite features a blend of clinically supported botanicals - Tongkat Ali, Panax ginseng, and Tribulus, to offer the much needed support that today's high-performing men deserve.
Tongkat Ali - Supports healthy testosterone and energy.
Panax Ginseng - Enhances stamina, focus, and resilience.
Tribulus Terrestris - Traditionally used to support libido and performance.
The launch of Ignite expands CV Sciences' growing portfolio of innovative wellness solutions. The Company has recently launched +PlusHLTH™, a cannabinoid-free supplement line, +PlusCBD™ Extra Support Sleep and Calm Gummies, +PlusCBD™ Reserve gummies, and new +PlusCBD™ pet products. For more information, please visit https://www.cvsciences.com/.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces cannabinoid-free supplements under its +PlusHLTH™ brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods™ brand provides a variety of 100% plant-based food products that are distributed primarily in the EU and other select markets. Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
Contact Information
[email protected]
SOURCE: CV Sciences, Inc.
View the original press release on ACCESS Newswire
B.Torres--AT